share_log

Benchmark Upgrades Exact Sciences to Buy, Announces $91 Price Target

Benzinga ·  Jan 2 06:59

Benchmark analyst Bruce Jackson upgrades Exact Sciences (NASDAQ:EXAS) from Hold to Buy and announces $91 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment